Evidence map›Paper›PMID 37563653›Full record

ArticleActa neuropathologica communications2023

A heterozygous splicing variant IVS9-7A > T in intron 9 of the MAPT gene in a patient with right-temporal variant frontotemporal dementia with atypical 4 repeat tauopathy.

Kohji Mori, Kazue Shigenobu, Goichi Beck, Ryota Uozumi, Yuto Satake, Maki Suzuki, Shizuko Kondo, Shiho Gotoh, Yuki Yonenobu, Makiko Kawai and 7 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Acta neuropathologica communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Kohji MoriDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, Japan. kmori@psy.med.osaka-u.ac.jp.ORCID http://orcid.org/0000-0003-2629-0723
Kazue ShigenobuDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, Japan.
Goichi BeckDepartment of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan.
Ryota UozumiDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, Japan.
Yuto SatakeDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, Japan.
Maki SuzukiDepartment of Behavioral Neurology and Neuropsychiatry, United Graduate School of Child Development, Osaka University, Suita, Japan.
Shizuko KondoDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, Japan.
Shiho GotohDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, Japan.
Yuki YonenobuDepartment of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan.
Makiko KawaiDepartment of Pathology, Graduate School of Medicine, Osaka University, Suita, Japan.
Yuki SuzukiDepartment of Psychiatry, Kansai Rosai Hospital, Amagasaki, Japan.
Yuko SaitoBrain Bank for Aging Research (Neuropathology), Tokyo Metropolitan Institute of Geriatrics and Gerontology, Tokyo, Japan.
Eiichi MoriiDepartment of Pathology, Graduate School of Medicine, Osaka University, Suita, Japan.
Masato HasegawaDementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Hideki MochizukiDepartment of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan.
Shigeo MurayamaDepartment of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan.
Manabu IkedaDepartment of Psychiatry, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, Japan. mikeda@psy.med.osaka-u.ac.jp.
The University of Osaka · JPTokyo Metropolitan Institute of Gerontology · JPKansai Rosai Hospital · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Right temporal variant frontotemporal dementia, also called right-predominant semantic dementia, often has an unclear position within the framework of the updated diagnostic criteria for behavioral variant frontotemporal dementia or primary progressive aphasia. Recent studies have suggested that this population may be clinically, neuropathologically, and genetically distinct from those with behavioral variant frontotemporal dementia or left-predominant typical semantic variant primary progressive aphasia. Here we describe a Japanese case of right temporal variant frontotemporal dementia with novel heterozygous MAPT mutation Adenine to Thymidine in intervening sequence (IVS) 9 at position -7 from 3' splicing site of intron 9/exon 10 boundary (MAPT IVS9-7A > T). Postmortem neuropathological analysis revealed a predominant accumulation of 4 repeat tau, especially in the temporal lobe, amygdala, and substantia nigra, but lacked astrocytic plaques or tufted astrocytes. Immunoelectron microscopy of the tau filaments extracted from the brain revealed a ribbon-like structure. Moreover, a cellular MAPT splicing assay confirmed that this novel variant promoted the inclusion of exon 10, resulting in the predominant production of 4 repeat tau. These data strongly suggest that the MAPT IVS9-7 A > T variant found in our case is a novel mutation that stimulates the inclusion of exon 10 through alternative splicing of MAPT transcript and causes predominant 4 repeat tauopathy which clinically presents as right temporal variant frontotemporal dementia.

Indexed as

Aphasia, Primary ProgressiveFrontotemporal DementiaPick Disease of the BrainTauopathiesHumansIntronsMutationtau ProteinsTemporal LobeMAPT protein, humantau ProteinsBehavioral variant frontotemporal dementiaFrontotemporal lobar degenerationIntronMAPTRight-temporal variant frontotemporal dementiaSplicing

Identifiers

PMID37563653
PMCPMC10413539
OpenAlexW4385739060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.